Covid-19 vaccine: Covovax gets emergency nod for 12-18 age group

Covid-19 vaccine: Covovax gets emergency nod for 12-18 age group

The Novavax vaccine is manufactured and marketed in India by SII under the brand name, Covovax. The Drugs Controller General of India (DCGI) has granted emergency use authorisation (EUA) for the Novavax and Serum Institute of India (SII) Covid-19 vaccine, Covovax, in the 12-18 age group. Covovax is the fourth vaccine to receive EUA from … Read more

DCGI grants emergency use permission to single-dose Sputnik Light Covid vaccine

Sputnik

The firm presented that Sputnik Light vaccine is approved in 29 countries, including Russia and Argentina. The Drugs Controller General of India has granted emergency use permission to single-dose Sputnik Light Covid vaccine in the country, Union Health Minister Mansukh Mandaviya said on Sunday. This comes following recommendations of an expert panel of India’s central … Read more

India’s vaccination drive picks up for adults but long road ahead for children

Covid

Covaxin phase 2/3 studies have been completed for 2 to 17 years age group population and immunogenicity and safety data have been submitted to the Drugs Controller General of India (DCGI) for further approvals. Even as India’s cumulative Covid-19 vaccination coverage exceeds 75.89 Crore, Covid-19 vaccination of children with comorbidities in the 12 to 17 … Read more

DCGI directs bulk drugs manufacturers to submit applications online of already issued valid WCCs

Bulk Drugs

Centre for Development of Advanced Computing (CDAC) in collaboration with Central Drugs Standard Control Organisation (CDSCO) has developed a module for online processing of applications for issuance of WCC as per the requirement of the European Union (EU). The Drugs Controller General of India (DCGI) has directed bulk drugs manufacturers to submit applications online of … Read more

Centre forms committee for framing new law for medicines, cosmetics, medical devices

drug act

The Drugs and Cosmetics (D&C) Act, 1940 regulates the import, manufacture, distribution and sale of drugs and cosmetics. The Union Health Ministry has formed a committee to frame the New Drugs, Cosmetics and Medical Devices Bill for the enactment of New Drugs, Cosmetics and Medical Devices Act. As per the terms of reference of the order … Read more

Hetero gets DCGI nod to launch biosimilar version of Tocilizumab

covid 19 vaccine

Hetero’s Tocilizumab 400mg/20ml is the biosimilar version of Roche’s Actemra/RoActemra drug. Tocilizumab is distributed by Cipla in India under licence from Roche. (Representational image) The Drug Controller General of India (DCGI) has granted Emergency Use Authorization (EUA) to Hetero for launching a biosimilar version of Tocilizumab, a Covid-19 drug for hospitalised adults. The Hyderabad-based company … Read more

Covid-19 Neutralizing Antibody Test critical for India’s fight against Coronavirus

WhatsApp Image 2021 08 26 at 13.34.23

WHO supports studies based on neutralizing antibody tests as they are critical for understanding infection’s extent and risk factors. By Jatin Mahajan, US Centre for Disease Control has recommended a 3rd dose of the Pfizer and Moderna Covid-19 vaccine for developing adequate antibodies amongst immunocompromised people. Some experts recommend a 3rd dose of Covishield six … Read more

Why rare diseases in India require robust government support to save patients’ lives

disease1200

Without any Government support for treatment, several patients have lost their lives in the interim. By Dr. Fauzia Khan Rare diseases affect only a small percentage of the populace in India or worldwide. The WHO definition uses the prevalence threshold as do most other countries, including India. This denotes a disease affecting less than one … Read more

Covid-19: Johnson and Johnson’s single-dose vaccine gets approval for Emergency Use in India

covid19

Representational Image In a development that will give a much-required push to vaccination drive in India, the Drug Controller General of India (DCGI) on Saturday gave emergency use authorisation (EUA) to the single-dose vaccine of Johnson and Johnson. “Johnson and Johnson’s single-dose COVID19 vaccine is given approval for Emergency Use in India,” tweeted Union Health … Read more

DCGI approved QR 678 formulation proves to be a differentiator from traditional hair transplant treatment

QR678 Vial

The QR 678 ® therapy has also demonstrated encouraging results in post chemotherapy induced hair loss, treatment of hair conditions like seborrheic dermatitis and in immunogenic diseases like alopecia areata. By Dr. Debraj Shome Drugs Controller General of India (DCGI) approved QR 678 has bridged the gap in the hair regrowth market and has proven … Read more